Cargando…
Safety and efficacy of intralesional steroid injection for aggressive fibromatosis
BACKGROUND: Treatment of recurrent aggressive fibromatosis (AF) following surgical resection is a clinical challenge. Non-steroidal anti-inflammatory drugs (NSAIDs) have been reported to be an effective option for controlling the disease. However, long-term NSAID use can result in unfavorable compli...
Autores principales: | Pruksakorn, Dumnoensun, Lorsomradee, Sratwadee, Phanphaisarn, Areerak, Teeyakasem, Pimpisa, Klangjorhor, Jeerawan, Chaiyawat, Parunya, Kosachunhanun, Natapong, Settakorn, Jongkolnee, Arpornchayanon, Olarn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667493/ https://www.ncbi.nlm.nih.gov/pubmed/29096658 http://dx.doi.org/10.1186/s12957-017-1262-9 |
Ejemplares similares
-
Expression patterns of class I histone deacetylases in osteosarcoma: a novel prognostic marker with potential therapeutic implications
por: Chaiyawat, Parunya, et al.
Publicado: (2018) -
Prognostic score for life expectancy evaluation of lung cancer patients after bone metastasis
por: Pruksakorn, Dumnoensun, et al.
Publicado: (2017) -
Surgical outcomes of extracorporeal irradiation and re-implantation in extremities for high grade osteosarcoma: A retrospective cohort study and a systematic review of the literature
por: Pruksakorn, Dumnoensun, et al.
Publicado: (2018) -
Endoplasmic reticulum protein 29 (ERp29) as a novel prognostic marker and tumor suppressor in osteosarcoma
por: Chaiyawat, Parunya, et al.
Publicado: (2019) -
Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma
por: Chaiyawat, Parunya, et al.
Publicado: (2017)